Akorn, Inc. Announces Second Quarter 2009 Earnings Release and Conference Call Information
LAKE FOREST, Ill., July 29 /PRNewswire-FirstCall/ -- Akorn, Inc. (Nasdaq: AKRX) will release second quarter 2009 earnings Tuesday, August 11 before the stock market opens. The company will host a conference call on Tuesday, August 11 to discuss quarterly results followed by a Q&A session:
Subject: Akorn Second Quarter 2009 Conference Call Date/Time: Tuesday, August 11, 2009 at 10:00 a.m. Eastern Time Domestic Callers: (800) 289-0479 International Callers: (913) 981-5519
URL For Webcast: http://www.videonewswire.com/event.asp?id=56168
The live broadcast of Akorn's conference call will also be available online at www.akorn.com under the investor relations tab on August 11, 2009, beginning at 10:00 a.m. (Eastern Time). The online replay will follow immediately and will be available for 30 days.
About Akorn, Inc.
Akorn, Inc. manufactures and markets sterile specialty pharmaceuticals. Akorn has manufacturing facilities located in Decatur, Illinois and Somerset, New Jersey and markets and distributes an extensive line of hospital and ophthalmic pharmaceuticals. Additional information is available at the Company's website at www.akorn.com.
This press release includes statements that may constitute "forward-looking statements", including with regard to the company's future operations and its earnings expectations. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Because such statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. You can identify these statements by the fact that they do not relate strictly to historical or current facts. They use words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," and other words and terms of similar meaning in connection with a discussion of future operating or financial performance. Factors that could cause or contribute to such differences include, but are not limited to: statements relating to future steps we may take, prospective products, future performance or results of current and anticipated products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, and financial results. These cautionary statements should be considered in connection with any subsequent written or oral forward-looking statements that may be made by the company or by persons acting on its behalf and in conjunction with its periodic SEC filings. You are advised, however, to consult any further disclosures we make on related subjects in our reports filed with the SEC. In particular, you should read the discussion in the section entitled "Cautionary Statement Regarding Forward-Looking Statements" in our most recent Annual Report on Form 10-K, as it may be updated in subsequent reports filed with the SEC. That discussion covers certain risks, uncertainties and possibly inaccurate assumptions that could cause our actual results to differ materially from expected and historical results. Other factors besides those listed there could also adversely affect our results
Contact: Tim Dick, Chief Financial Officer (847) 279-6150
SOURCE Akorn, Inc.